In conclusion, Choi et al. [1] identified DRG2 as a critical regulator of PD-L1 endosomal trafficking in cancer cells, which is essential for the proper localization of PD-L1 on the cell surface and, consequently, for an effective response to ICIs. Here, DRG2 is linked to cancer.